Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 207,538 shares at $410.00 ($83.7M) on 2014-10-28, disclosed to the SEC on 2014-10-29.
Scheduled sale ($83.7M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $402.69 | 125,198 | $50.4M | 60.3% |
| 2 | $402.69 | 5,145 | $2.1M | 2.5% |
| 3 | $402.69 | 7,226 | $2.9M | 3.5% |
| 4 | $402.69 | 857 | $345K | 0.4% |
| 5 | $400.52 | 12,322 | $4.9M | 5.9% |
| 6 | $401.45 | 10,381 |
| $4.2M |
| 5.0% |
| 7 | $402.54 | 3,318 | $1.3M | 1.6% |
| 8 | $403.38 | 12,250 | $4.9M | 5.9% |
| 9 | $404.46 | 2,250 | $910K | 1.1% |
| 10 | $405.76 | 5,900 | $2.4M | 2.9% |
| 11 | $406.50 | 14,052 | $5.7M | 6.8% |
| 12 | $407.31 | 4,350 | $1.8M | 2.1% |
| 13 | $408.62 | 2,400 | $981K | 1.2% |
| 14 | $409.43 | 1,789 | $732K | 0.9% |
| 15 | $410.00 | 100 | $41K | 0.0% |
| Total | $403.13 avg | 207,538 | $83.7M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |